This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
. Crimean-Congo haemorrhagic fever. Antiviral Research
2004; 64: 145–160.
2.O Ergonul . Crimean-Congo haemorrhagic fever. Lancet Infectious Diseases 2006; 6: 203–214.
3.M Saijo , S Morikawa , I Kurane . Recent progress in the treatment for Crimean-Congo haemorrhagic fever and future perspectives. Future Virology 2010; 5: 801–809.
4.P Sidira , Seroepidemiological study of Crimean-Congo haemorrhagic fever in Greece, 2009–2010. Clinical Microbiology and Infection 2012; 18: E16–19.
5.RM Vorou , VG Papavassiliou , S Tsiodras . Emerging zoonoses and vector-borne infections affecting humans in Europe. Epidemiology and Infection 2007; 135: 1231–1247.
7.NS Gunaydin , Crimean-Congo haemorrhagic fever cases in the eastern Black Sea Region of Turkey: demographic, geographic, climatic, and clinical characteristics. Turkish Journal of Medical Sciences 2010; 40: 829–834.
8.GR Yilmaz , The epidemiology of Crimean-Congo haemorrhagic fever in Turkey, 2002–2007. International Journal of Infectious Diseases 2009; 13: 380–386.
9.S Chinikar , Crimean-Congo haemorrhagic fever in Iran and neighboring countries. Journal of Clinical Virology 2010; 47: 110–114.
10.O Ergonul . Crimean-Congo haemorrhagic fever virus: new outbreaks, new discoveries. Current Opinion in Virology 2012; 2: 215–220.
. Crimean-Congo haemorrhagic fever virustick survey in endemic areas in Bulgaria. Journal of Medical Virology
2012; 84: 608–614.
12.H Bodur , Subclinical infections with Crimean-Congo haemorrhagic fever virus, Turkey. Emerging Infectious Diseases 2012; 18: 640–642.
13.S Izadi , Crimean-Congo haemorrhagic fever in Sistan and Baluchestan Province of Iran, a case-control study on epidemiological characteristics. International Journal of Infectious Diseases 2004; 8: 299–306.
15.RJ Williams , Crimean-congo haemorrhagic fever: a seroepidemiological and tick survey in the Sultanate of Oman. Tropical Medicine and International Health 2000; 5: 99–106.
17.CC Mathiot , Antibodies to haemorrhagic fever viruses in Madagascar populations. Transactions of the Royal Society Tropical Medicine and Hygiene 1989; 83: 407–409.
19.O Ergonul , Zoonotic infections among veterinarians in Turkey: Crimean-Congo haemorrhagic fever and beyond. International Journal of Infectious Diseases 2006; 10: 465–469.
20.O Ergonul , The lack of Crimean-Congo haemorrhagic fever virus antibodies in healthcare workers in an endemic region. International Journal of Infectious Diseases 2007; 11: 48–51.
21.T Gunes , Crimean-Congo haemorrhagic fever virus in high-risk population, Turkey. Emerging Infectious Diseases 2009; 15: 461–464.
22.B Ertugrul , The seroprevalence of Crimean-Congo haemorrhagic fever among inhabitants living in the endemic regions of Western Anatolia. Scandinavian Journal of Infectious Diseases 2012; 44: 276–281.
23.Z Vatansever , Crimean-Congo haemorrhagic fever in Turkey. In: O Ergonul , CA Whitehouse , eds. Crimean-Congo Haemorrhagic Fever: A Global Perspective. Amsterdam: Springer, 2007, pp. 59–74.
24.I Koksal , The efficacy of ribavirin in the treatment of Crimean-Congo haemorrhagic fever in Eastern Black Sea region in Turkey. Journal of Clinical Virology 2010; 47: 65–68.
Crimean-Congo haemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. Journal of Infection
2006; 52: 207–215.
26.O Ergonul , The characteristics of Crimean-Congo haemorrhagic fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy. Clinical Infectious Diseases 2004; 39: 284–288.
27.A Tarantola , E Ergonul , P Tattevin . Estimates and prevention of Crimean Congo haemorrhagic fever risks for health-care workers. In: O Ergonul , CA Whithouse , eds. Crimean-Congo Haemorrhagic Fever: A Global Perspective. Amsterdam: Springer, 2007, pp. 281–294.
28.S Kirdar , MB Ertugrul . Crimean-Congo haemorrhagic fever [in Turkish]. Journal of Adnan Menderes Medical Faculty 2009; 10: 45–52.
29.MA Cevik , Viral load as a predictor of outcome in Crimean-Congo haemorrhagic fever. Clinical Infectious Diseases 2007; 45: 96–100.
30.A Saksida , Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo haemorrhagic fever. Clinical and Vaccine Immunology 2010; 17: 1086–1093.
31.MA Cevik , Clinical and laboratory features of Crimean-Congo haemorrhagic fever: predictors of fatality. International Journal of Infectious Diseases 2008; 12: 374–379.
32.R Vorou , IN Pierroutsakos , HC Maltezou . Crimean-Congo haemorrhagic fever. Current Opinion in Infectious Diseases 2007; 20: 495–500.